Which of the following is true about allodynia?
The Visual Analog Scale (VAS) is a type of:
Which of the following drugs can be administered intravenously, epidurally, or via the transdermal route?
Which one of the following best describes allodynia in pain management?
Which of the following statements regarding Complex Regional Pain Syndrome (CRPS) is false?
A female patient underwent mastectomy for carcinoma of the breast. A few days after surgery, she experienced burning pain along the medial aspect of her arm. What is the most likely cause of this pain?
Which of the following is true about the WHO analgesic ladder for chronic pain in adults?
What is the most potent analgesic?
A patient reports pain rated as 8 on a scale of 1 to 10. Which intervention should the nurse implement?
Pain relief in acupuncture is mediated by which of the following?
Explanation: **Explanation:** **Allodynia** is defined by the International Association for the Study of Pain (IASP) as **pain due to a stimulus that does not normally provoke pain**. It is a hallmark of neuropathic pain and central sensitization. In this condition, the threshold for pain is lowered such that innocuous stimuli (like a light touch, the brush of clothing, or a breeze) are perceived as painful. **Analysis of Options:** * **Option C (Correct):** This directly matches the definition. It involves a change in the *quality* of sensation, where a non-noxious stimulus triggers a pain response. * **Option A (Incorrect):** **Hyperalgesia** is an *increased* response to a stimulus that is *normally* painful (e.g., a pinprick feeling like a stab). While both involve sensitization, allodynia involves a non-painful trigger, whereas hyperalgesia involves a painful one. * **Option B (Incorrect):** Loss of sensory sensation is termed **anesthesia** or **hypesthesia**. Allodynia is a positive sensory phenomenon (gain of function), not a loss. * **Option D (Incorrect):** **Hyperesthesia** is a broad term referring to increased sensitivity to any stimulus (touch, thermal, etc.), not specifically the conversion of a non-painful stimulus into pain. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Allodynia is primarily mediated by **A-beta fibers** (normally responsible for light touch) "shunting" signals into the pain pathways due to central sensitization in the spinal cord dorsal horn. * **Dynamic vs. Static:** Allodynia can be **mechanical** (moving a cotton wisp) or **thermal** (mild warmth feeling like a burn). * **Common Clinical Scenarios:** Post-herpetic neuralgia, Migraine (scalp tenderness), and Complex Regional Pain Syndrome (CRPS).
Explanation: **Explanation:** The **Visual Analog Scale (VAS)** is one of the most commonly used tools in clinical practice for the **subjective assessment of pain intensity**. It typically consists of a 10 cm (100 mm) horizontal line, anchored by two extremes: "No pain" at the 0 cm mark and "Worst imaginable pain" at the 10 cm mark. The patient marks a point on the line that represents their current pain level, and the distance is measured to provide a numerical value. **Analysis of Options:** * **Option A (Correct):** VAS is a validated psychometric response scale used to quantify pain. It is highly sensitive to changes in pain intensity, making it ideal for monitoring the efficacy of analgesic interventions. * **Option B (Incorrect):** Pressure assessment (e.g., compartment pressure or intracranial pressure) requires objective manometry or transducers, not subjective visual scales. * **Option C (Incorrect):** Vision is assessed using tools like the Snellen chart or Jaeger card. While the name "Visual" in VAS refers to the patient looking at the scale, it does not measure visual acuity. * **Option D (Incorrect):** Auditory function is assessed via audiometry or tuning fork tests (Rinne/Weber). **NEET-PG High-Yield Pearls:** * **Unidimensional vs. Multidimensional:** VAS is a **unidimensional** scale (measures only intensity). The McGill Pain Questionnaire is an example of a **multidimensional** scale (measures quality and emotional impact). * **Pediatric Use:** For children (usually >3 years), the **Wong-Baker FACES Pain Rating Scale** is preferred over the VAS. * **FLACC Scale:** Used for infants or non-verbal patients (Face, Legs, Activity, Cry, Consolability). * **Gold Standard:** The patient’s self-report is considered the "gold standard" for pain assessment.
Explanation: **Explanation:** **Fentanyl** is a potent synthetic opioid agonist that is highly lipophilic. This high lipid solubility allows it to cross biological membranes easily, making it uniquely versatile in its routes of administration. It can be administered: * **Intravenously:** For induction and maintenance of anesthesia or acute pain relief. * **Epidurally/Intrathecally:** It provides rapid-onset regional analgesia by acting on opioid receptors in the spinal cord. * **Transdermally:** Formulated as a patch for chronic pain management, providing a steady release of the drug over 72 hours. * **Other routes:** It is also available in transmucosal (lozenge/buccal) and intranasal forms. **Why the other options are incorrect:** * **Thiopentone (A):** An ultra-short-acting barbiturate used primarily for intravenous induction of anesthesia. It is highly alkaline and would cause tissue necrosis if given via non-vascular routes; it is never used epidurally or transdermally. * **Succinylcholine (B):** A depolarizing neuromuscular blocker administered IV or IM (in emergencies). It is a highly ionized quaternary ammonium compound, meaning it cannot cross lipid membranes or the blood-brain barrier, making transdermal or neuraxial administration ineffective. * **Vecuronium (C):** A non-depolarizing neuromuscular blocker. Like succinylcholine, it is ionized and acts specifically at the nicotinic receptors of the neuromuscular junction. It is administered strictly intravenously. **High-Yield Clinical Pearls for NEET-PG:** * **Potency:** Fentanyl is approximately **75–100 times more potent than Morphine**. * **Context-Sensitive Half-Life:** Fentanyl has a short duration of action after a single bolus due to **redistribution**, but its context-sensitive half-life increases significantly with prolonged infusions. * **Side Effect:** A unique side effect of rapid high-dose IV Fentanyl is **"Wooden Chest Syndrome"** (chest wall rigidity), which can make ventilation difficult.
Explanation: **Explanation:** **Allodynia** is defined by the International Association for the Study of Pain (IASP) as **pain due to a stimulus that does not normally provoke pain.** In clinical practice, this means a non-noxious stimulus—such as a light touch, the brushing of clothes against the skin, or a gentle breeze—is perceived by the patient as painful. It is a hallmark of neuropathic pain and reflects **central sensitization**, where second-order neurons in the spinal cord become hypersensitive to low-threshold mechanoreceptor input. **Analysis of Options:** * **Option A & B (Absence/Lack of pain):** These describe **Analgesia** (absence of pain in response to stimulation which would normally be painful) or **Anesthesia** (total loss of all sensation). * **Option C (Unpleasant sensation):** This describes **Dysesthesia**, which is an abnormal, unpleasant sensation that can be spontaneous or evoked. While allodynia is unpleasant, dysesthesia is a broader term that doesn't specifically require a non-noxious trigger. * **Option D (Correct):** Accurately defines allodynia as the perception of pain from a stimulus that is ordinarily non-painful. **High-Yield Clinical Pearls for NEET-PG:** * **Hyperalgesia:** An increased response to a stimulus that is *normally* painful (e.g., a pinprick feeling like a stab). * **Hyperpathia:** An explosive, painful reaction to a stimulus, especially a repetitive one, often with an increased threshold. * **Mechanism:** Allodynia involves the recruitment of **A-beta fibers** (which normally carry touch) to transmit pain signals to the brain due to neuroplastic changes in the dorsal horn. * **Common Clinical Scenarios:** Post-herpetic neuralgia, complex regional pain syndrome (CRPS), and fibromyalgia.
Explanation: ### Explanation **1. Why Option A is the Correct Answer (The False Statement):** The fundamental distinction between the two types of Complex Regional Pain Syndrome (CRPS) lies in the presence of a documented nerve injury. * **CRPS Type 1** (formerly known as **Reflex Sympathetic Dystrophy**) occurs **without** a definable nerve injury. It usually follows a minor trauma, fracture, or surgery. * **CRPS Type 2** (formerly known as **Causalgia**) occurs specifically **following** a documented major nerve injury. Therefore, stating that Type 1 occurs following a nerve injury is factually incorrect. **2. Analysis of Other Options:** * **Option B:** This is true. The older nomenclature for CRPS Type 1 is Reflex Sympathetic Dystrophy (RSD), while Type 2 was termed Causalgia. * **Option C:** This is true. The pathophysiology involves "sympathetically maintained pain," where damaged or sensitized nociceptors develop an abnormal expression of adrenoceptors, making them hypersensitive to circulating catecholamines (adrenergic sensitivity). * **Option D:** This is true. Management is multidisciplinary. Most cases of CRPS Type 1 respond well to physical therapy, neuropathic pain medications (Gabapentin/Amitriptyline), and sympathetic blocks if initiated early. **3. High-Yield Clinical Pearls for NEET-PG:** * **Budapest Criteria:** The gold standard for clinical diagnosis (includes sensory, vasomotor, sudomotor, and motor/trophic changes). * **Clinical Features:** Characterized by **allodynia** (pain from non-painful stimuli) and **hyperalgesia** (exaggerated pain), often accompanied by skin color and temperature changes. * **Treatment of Choice:** Physical therapy is the cornerstone. For refractory cases, **Stellate Ganglion Block** (for upper limb) or **Lumbar Sympathetic Block** (for lower limb) is used. * **Vitamin C Prophylaxis:** Administration of Vitamin C after distal radius fractures is known to reduce the incidence of CRPS.
Explanation: **Explanation:** The correct answer is **Intercostobrachial neuralgia**. This is a common complication following mastectomy or axillary lymph node dissection (ALND), occurring in up to 20-50% of patients. **1. Why Intercostobrachial Neuralgia is Correct:** The **intercostobrachial nerve (ICBN)** is the lateral cutaneous branch of the second intercostal nerve (T2). It provides sensory innervation to the **skin of the axilla and the medial aspect of the upper arm**. During mastectomy or axillary clearance, this nerve is frequently stretched, compressed, or severed. Injury leads to neuropathic symptoms, typically described as **burning, tingling, or lancinating pain** localized specifically to the medial arm and axilla. **2. Analysis of Incorrect Options:** * **Phantom breast pain:** This refers to the sensation of pain in the tissue that has been removed (the breast itself). While common after mastectomy, it does not localize to the medial arm. * **Neuroma pain:** This occurs due to disorganized axonal regrowth at the site of a nerve transection. While it causes neuropathic pain, it usually presents later (weeks to months) and is localized to a specific trigger point or the surgical scar rather than a dermatomal distribution like the medial arm. * **Other nerve injury pain:** While nerves like the long thoracic or thoracodorsal can be injured, they are primarily **motor nerves**. Injury to these would result in functional deficits (e.g., winged scapula) rather than sensory burning pain in the arm. **Clinical Pearls for NEET-PG:** * **Post-Mastectomy Pain Syndrome (PMPS):** A chronic neuropathic pain condition lasting >3 months. The ICBN is the most commonly implicated nerve. * **Nerve Origin:** ICBN originates from the **T2 spinal level**. * **Management:** Initial treatment involves neuropathic agents like Gabapentin, Pregabalin, or Amitriptyline. Regional blocks (e.g., Paravertebral block) can be used for prevention.
Explanation: The WHO Analgesic Ladder is a cornerstone of pain management, originally designed for cancer pain but now widely applied to chronic pain. It follows a stepwise approach based on pain intensity. ### **Explanation of the Correct Option** **B. Morphine is used for severe pain:** Morphine is the "gold standard" strong opioid. According to the WHO ladder, **Step 3** (Severe pain, VAS 7–10) involves the use of strong opioids like Morphine, Fentanyl, or Hydromorphone, with or without non-opioids and adjuvants. ### **Analysis of Incorrect Options** * **A. Analgesics are given 'as needed':** This is incorrect. The WHO principle is **"By the Clock."** Medications should be administered at fixed intervals to maintain a constant plasma concentration and prevent pain recurrence, rather than waiting for the pain to return (PRN). * **C. Adjuvants are indicated only for mild pain:** Incorrect. Adjuvants (e.g., anticonvulsants like Gabapentin or antidepressants like Amitriptyline) can be used at **any step** of the ladder to manage neuropathic components or enhance the efficacy of primary analgesics. * **D. Non-opioid analgesics are given for moderate pain:** While non-opioids (NSAIDs/Acetaminophen) are used in moderate pain, they are the primary treatment for **Step 1 (Mild pain)**. Moderate pain (**Step 2**) specifically requires the addition of **weak opioids** (e.g., Codeine, Tramadol). ### **High-Yield NEET-PG Pearls** * **The Five Principles:** 1. By the mouth (oral preferred), 2. By the clock (fixed intervals), 3. By the ladder (stepwise), 4. For the individual (tailored dosing), 5. Attention to detail. * **Step 1:** Non-opioids (NSAIDs, Paracetamol). * **Step 2:** Weak opioids (Tramadol, Codeine). * **Step 3:** Strong opioids (Morphine, Fentanyl). * **Step 4 (Recent addition):** Interventional techniques (e.g., Epidural, Neurolytic blocks, PCA pumps).
Explanation: **Explanation:** The potency of an analgesic refers to the dose required to produce a specific intensity of effect. In clinical practice, opioid potency is typically measured against **Morphine**, which serves as the standard reference (potency = 1). **Why Sufentanil is Correct:** Sufentanil is a thienyl analogue of fentanyl and is currently the **most potent opioid analgesic** used in clinical human practice. It is approximately **5 to 10 times more potent than Fentanyl** and **500 to 1,000 times more potent than Morphine**. Its high lipid solubility allows it to cross the blood-brain barrier rapidly, providing an immediate onset of action and intense analgesia, primarily used in cardiac anesthesia and for patients with high opioid tolerance. **Analysis of Incorrect Options:** * **COX-2 Inhibitors:** These are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). While effective for inflammatory pain, their ceiling effect and peripheral mechanism make them significantly less potent than pure mu-opioid agonists. * **Morphine:** The "gold standard" for pain relief, but it is the least potent on this list. It has slow CNS penetration due to low lipid solubility. * **Remifentanil:** A potent ultra-short-acting opioid, but its potency is roughly equal to or slightly less than Fentanyl (approx. 100–200 times Morphine), making it significantly less potent than Sufentanil. **High-Yield Clinical Pearls for NEET-PG:** * **Potency Hierarchy:** Sufentanil > Fentanyl ≈ Remifentanil > Alfentanil > Morphine > Pethidine. * **Carfentanil:** While not used in humans (used in veterinary medicine for large animals), it is the most potent opioid overall (10,000x Morphine). * **Context-Sensitive Half-Life:** Remifentanil is unique because it is metabolized by **plasma esterases**, giving it the shortest context-sensitive half-life, regardless of infusion duration. * **Sufentanil** has the smallest volume of distribution among the fentanyls, contributing to its rapid recovery profile after short infusions.
Explanation: ### Explanation **1. Why Option D is Correct:** In clinical practice, a high pain score (8/10) is a significant clinical finding that requires immediate **assessment before intervention**. While pain management is a priority, sudden or severe pain can be a "red flag" for life-threatening complications such as compartment syndrome, myocardial infarction, pulmonary embolism, or internal hemorrhage. Administering analgesics (especially opioids) without assessment can mask these evolving symptoms, leading to a delay in diagnosis and potentially fatal outcomes. The medical priority is always **Assessment → Diagnosis → Intervention.** **2. Why Other Options are Incorrect:** * **Option A:** While timely analgesia is important, administering medication without a quick focused assessment is unsafe. One must ensure the pain is "expected" (e.g., post-operative) rather than "pathological" (e.g., a new complication). * **Option B:** Guided imagery is a complementary therapy. It is inappropriate as a standalone treatment for severe pain (8/10) and should never replace pharmacological intervention in acute settings. * **Option C:** Discouraging medication is unethical and violates the principle of beneficence. Pain is what the patient says it is, and severe pain must be managed to prevent physiological stress responses. **3. NEET-PG Clinical Pearls:** * **WHO Analgesic Ladder:** For severe pain (7–10), the recommendation is to start at **Step 3**: Strong opioids (e.g., Morphine, Fentanyl) ± non-opioids. * **Vital Signs:** Always check for tachycardia and hypertension as physiological markers of pain, but remember that their absence does not disprove the patient's report. * **The "Fifth Vital Sign":** Pain is considered the fifth vital sign; however, the first step in managing any abnormal vital sign is to identify the underlying cause. * **Post-Op Alert:** In a post-surgical patient, sudden severe pain unresponsive to usual doses is the earliest sign of **Compartment Syndrome**.
Explanation: **Explanation:** The correct answer is **Endogenous opioids**. Acupuncture works primarily through the **Gate Control Theory** and the stimulation of the body’s natural descending inhibitory pathways. When acupuncture needles are inserted into specific "acupoints," they stimulate A-delta and C-fibers. This sensory input triggers the release of **endogenous opioids**—specifically **endorphins, enkephalins, and dynorphins**—within the gray matter of the midbrain and the spinal cord. These substances bind to opioid receptors (mu, delta, and kappa), effectively blocking the transmission of pain signals. This mechanism is supported by the fact that the analgesic effect of acupuncture can be partially or fully reversed by **Naloxone** (an opioid antagonist). **Why the other options are incorrect:** * **Kinins (e.g., Bradykinin):** These are potent inflammatory mediators that **sensitize** nociceptors and promote pain (hyperalgesia) rather than relieving it. * **Substance P:** This is a neurotransmitter released from C-fibers that **transmits** pain signals to the dorsal horn of the spinal cord. It is pro-nociceptive. * **Prostaglandins:** These are lipid compounds produced at sites of tissue damage that **enhance** the sensitivity of pain receptors. Drugs like NSAIDs work by inhibiting prostaglandins to reduce pain. **High-Yield Clinical Pearls for NEET-PG:** * **Naloxone Reversibility:** The most definitive proof that acupuncture works via the opioid system is its reversibility by Naloxone. * **Neurotransmitters involved:** Besides opioids, acupuncture is also thought to modulate **Serotonin (5-HT)** and **Norepinephrine** in the descending inhibitory tracts. * **TENS vs. Acupuncture:** Like acupuncture, Transcutaneous Electrical Nerve Stimulation (TENS) also utilizes the Gate Control Theory to achieve analgesia.
Pain Physiology and Pathways
Practice Questions
Acute Pain Management
Practice Questions
Chronic Pain Syndromes
Practice Questions
Neuropathic Pain
Practice Questions
Multimodal Analgesia
Practice Questions
Opioid Pharmacology
Practice Questions
Non-opioid Analgesics
Practice Questions
Adjuvant Analgesics
Practice Questions
Patient-Controlled Analgesia
Practice Questions
Interventional Pain Procedures
Practice Questions
Cancer Pain Management
Practice Questions
Perioperative Pain Management
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free